This topic contains a solution. Click here to go to the answer

Author Question: The client is receiving warfarin (Coumadin). Which laboratory result will the nurse monitor to ... (Read 49 times)

arivle123

  • Hero Member
  • *****
  • Posts: 569
The client is receiving warfarin (Coumadin). Which laboratory result will the nurse monitor to evaluate the therapeutic response?
 
  1. WBC
  2. PT and INR
  3. BNP
  4. aPTT

Question 2

The client is receiving heparin (Hep-Lock). The nurse will monitor which laboratory results to evaluate therapeutic response?
 
  1. INR
  2. aPTT
  3. BNP
  4. PT



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

izzat

  • Sr. Member
  • ****
  • Posts: 328
Answer to Question 1

2

Rationale 1: WBC is used to determine infection.
Rationale 2: PT and INR should be monitored for a client receiving warfarin (Coumadin) therapy.
Rationale 3:BNP is incorrect because this lab result does not pertain to clotting.
Rationale 4:aPTT is incorrect because this should be monitored for a client receiving heparin therapy.

Global Rationale: PT and INR should be monitored for a client receiving warfarin (Coumadin) therapy. PT is incorrect because it should be monitored with INR for a client receiving warfarin (Coumadin) therapy. BNP is incorrect because this lab result does not pertain to clotting. aPTT is incorrect because this should be monitored for a client receiving heparin therapy.

Answer to Question 2

2

Rationale 1:INR is incorrect because it should be monitored for a client receiving warfarin (Coumadin) therapy.
Rationale 2: To avoid serious adverse effects, drug therapy with coagulation-modifier drugs is individualized to each patient and must be carefully monitored. For heparin, the activated partial thromboplastin time (aPTT) is used.
Rationale 3: BNP or beta natriuretic peptide is used for the severity rate of congestive heart failure.
Rationale 4:PT is incorrect because it should be monitored for a client receiving warfarin (Coumadin) therapy.

Global Rationale: To avoid serious adverse effects, drug therapy with coagulation-modifier drugs is individualized to each patient, and must be carefully monitored. For heparin, the activated partial thromboplastin time (aPTT) is used. PT and INRare incorrect because they should be monitored for a client receiving warfarin (Coumadin) therapy. BNP is incorrect because this lab result does not pertain to clotting.




arivle123

  • Member
  • Posts: 569
Reply 2 on: Jul 23, 2018
Great answer, keep it coming :)


mcabuhat

  • Member
  • Posts: 344
Reply 3 on: Yesterday
Gracias!

 

Did you know?

Vital signs (blood pressure, temperature, pulse rate, respiration rate) should be taken before any drug administration. Patients should be informed not to use tobacco or caffeine at least 30 minutes before their appointment.

Did you know?

The horizontal fraction bar was introduced by the Arabs.

Did you know?

Blood is approximately twice as thick as water because of the cells and other components found in it.

Did you know?

About 3.2 billion people, nearly half the world population, are at risk for malaria. In 2015, there are about 214 million malaria cases and an estimated 438,000 malaria deaths.

Did you know?

In the United States, congenital cytomegalovirus causes one child to become disabled almost every hour. CMV is the leading preventable viral cause of development disability in newborns. These disabilities include hearing or vision loss, and cerebral palsy.

For a complete list of videos, visit our video library